Drug patent protection: it's time for a 'one-and-done' approach - STAT

Drug patent protection: it's time for a 'one-and-done' approach - STAT

More reads

• 'One and done' for new drugs could cut patent thickets and boost generic competition. (STAT)
• Guangzhou offers carrots to win over international biotech players in race to catch up with Beijing and Shanghai (South China Morning Post)
• Should J&J win an OK for a flawed depression drug after notable trial failures?  (Endpoints)